Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothermia in Acute Stroke.

D Georgiadis1, Stefan Schwab

  • 1Department of Neurology, University of Heidelberg, IM Neuenheimer Feld, 40069120 Heidelberg, Germany. Stefan_schwab@med.uni-heidelberg.de.

Current Treatment Options in Neurology
|January 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center.

Neurological research and practice·2025
Same author

Long-Term Survival, Burden of Disease, and Patient-Centered Outcomes in Maximally Treated Intracerebral Hemorrhage.

Annals of clinical and translational neurology·2025
Same author

Factors influencing neurologists' prescribing of antiseizure medication: The role of physician biography and patient characteristics.

Seizure·2025
Same author

Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis.

Neurological research and practice·2025
Same author

Cerebral lesions in the central pain matrix are associated with headache in multiple sclerosis.

Scientific reports·2025
Same author

Fortschritte der Neurologie-Psychiatrie·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Moderate hypothermia (MH) shows neuroprotective effects in animal stroke models. In human stroke patients, MH may reduce mortality but requires specialized care and further research for efficacy.

Area of Science:

  • Neurology
  • Critical Care Medicine

Background:

  • Moderate hypothermia (MH) demonstrates neuroprotection in animal models of focal ischemia.
  • Observational studies in acute stroke patients suggest normothermia or mild hypothermia are prognostic factors for favorable outcomes.

Purpose of the Study:

  • To review the current evidence on the neuroprotective effects of moderate hypothermia in human stroke patients.
  • To assess the feasibility, safety, and potential efficacy of moderate hypothermia in acute stroke.

Main Methods:

  • Review of existing clinical studies and observational data on moderate hypothermia in stroke patients.
  • Analysis of reported side effects, treatment intensity, and intensive care unit stay associated with MH.

Main Results:

Related Experiment Videos

  • Limited clinical data suggest moderate hypothermia may reduce mortality in malignant middle cerebral artery infarction.
  • One clinical study indicated feasibility and safety of mild hypothermia, but lacked power for efficacy assessment.
  • MH in humans is linked to side effects, intensive medical treatment, and prolonged ICU stays.

Conclusions:

  • Moderate hypothermia shows potential as a neuroprotective therapy for acute stroke, particularly in severe cases.
  • Current use of MH in humans should be restricted to specialized units within research or observational studies due to associated risks and limited efficacy data.
  • Further large-scale clinical trials are needed to establish the efficacy of moderate hypothermia for stroke treatment.